Aspyrian Therapeutics, Inc. is a privately funded clinical stage biotechnology company developing a new class of precision targeted oncologic drugs for the treatment of solid tumors based on the photoimmunotherapy platform. We are developing drugs based on this platform to create a new paradigm for…
Aspyrian Therapeutics, Inc. is a privately funded clinical stage biotechnology company developing a new class of precision targeted oncologic drugs for the treatment of solid tumors based on the photoimmunotherapy platform. We are developing drugs based on this platform to create a new paradigm for cancer treatment and enable the Medical Oncologists and Surgeons to manage both the primary tumor and systemic disease.
We are for the cancer patients, to offer them the possibility to battle cancer, to cure the disease, with precision targeted medicines. We create a new way to fight cancer, with uncompromised science, passion and commitment.
Team (1)
Sectors Aspyrian Therapeutics serves:
Life Sciences
Join Axial's Private M&A Platform
Aspyrian Therapeutics connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
